Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vancomycin Powder in Open Fractures
NCT02400112Phase 4Terminated
- Sponsor
- University of Tennessee
- Start
- Mar 2015
- Primary completion
- Oct 2018
- Modality
- Cyclic Peptides, Antimicrobial Peptides, Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of vancomycin in surgical site infection (SSI), sponsored by University of Tennessee. Started Mar 2015; status: terminated.
02
Drugs
vancomycin
03
Conditions
surgical site infection (SSI)
Beyond the preview
Go deeper on NCT02400112.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02400112.